What were Gaudium IVF and Women Health Ltd's latest quarterly results?
Gaudium IVF and Women Health Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +6.8%
- Revenue Growth YoY: +70.0%
- Operating Margin: 26.8%
Gaudium IVF and Women Health Ltd: Stock Analysis & Fundamentals
Updated this weekGaudium IVF and Women Health Ltd (Hospitals/Medical Services) — fundamental analysis, earnings data, and key metrics. PE: 28.4. ROE: 52.2%. This stock is not currently in the Nifty 500 momentum outperformers list.
Key Numbers
Current Price
₹75
Market Cap
549 Cr
Valuation
N/AOther Top Hospitals/Medical Services Stocks Beating Nifty 500
Frequently Asked Questions: Gaudium IVF and Women Health Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Gaudium IVF and Women Health Ltd's current PE ratio?
Gaudium IVF and Women Health Ltd's current PE ratio is 28.4x.
- Current PE: 28.4x
- Market Cap: 549 Cr
Is Gaudium IVF and Women Health Ltd a fundamentally strong company?
Gaudium IVF and Women Health Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 49.0%
Is Gaudium IVF and Women Health Ltd debt free?
Gaudium IVF and Women Health Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹24 Cr
What is Gaudium IVF and Women Health Ltd's return on equity (ROE) and ROCE?
Gaudium IVF and Women Health Ltd's return ratios over recent years
- FY2023: ROCE 76.0%
- FY2024: ROCE 45.0%
- FY2025: ROCE 49.0%
Is Gaudium IVF and Women Health Ltd's cash flow positive?
Gaudium IVF and Women Health Ltd's operating cash flow is positive (FY2025).
- Cash from Operations (CFO): ₹9 Cr
- Free Cash Flow (FCF): ₹-6 Cr
- CFO/PAT Ratio: 47% (weak cash conversion)
What is Gaudium IVF and Women Health Ltd's dividend yield?
Gaudium IVF and Women Health Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹75
Who holds Gaudium IVF and Women Health Ltd shares — promoters, FII, DII?
Gaudium IVF and Women Health Ltd's shareholding pattern (Feb 2026)
- Promoters: 71.3%
- FII (Foreign): 9.2%
- DII (Domestic): 5.1%
- Public: 14.4%
Is Gaudium IVF and Women Health Ltd a new momentum entry or an established outperformer?
Gaudium IVF and Women Health Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Gaudium IVF and Women Health Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Gaudium IVF and Women Health Ltd may be worth studying
- Cash flow is positive — CFO ₹9 Cr
What is the investment thesis for Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd investment thesis summary:
What is the future outlook for Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.